₹ 0.7 Cr
Volume Transacted
(Nov 22, 2024)
5.0 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Net Profit
₹ 354.49
Last updated on: Nov 23, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1480.05 | 1474.95 | 1486.05 | 1451.8 |
21 Nov 2024 | 1465.3 | 1494.45 | 1494.45 | 1458.85 |
19 Nov 2024 | 1492.35 | 1504.95 | 1517.95 | 1472.25 |
18 Nov 2024 | 1483.5 | 1561.65 | 1581 | 1477.35 |
14 Nov 2024 | 1531.7 | 1540.25 | 1559.2 | 1522.2 |
13 Nov 2024 | 1538.5 | 1560.15 | 1574.65 | 1522.8 |
12 Nov 2024 | 1577.25 | 1634.65 | 1634.65 | 1550.15 |
11 Nov 2024 | 1634.7 | 1665 | 1682.65 | 1632.6 |
08 Nov 2024 | 1665.5 | 1670 | 1681 | 1647.65 |
07 Nov 2024 | 1657.7 | 1763.65 | 1771.95 | 1645.05 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1480.05 |
21 Nov 2024 | 1465.3 |
19 Nov 2024 | 1492.35 |
18 Nov 2024 | 1483.5 |
14 Nov 2024 | 1531.7 |
13 Nov 2024 | 1538.5 |
12 Nov 2024 | 1577.25 |
11 Nov 2024 | 1634.7 |
08 Nov 2024 | 1665.5 |
07 Nov 2024 | 1657.7 |
Historical Revenue of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Glenmark Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Glenmark Pharmaceuticals Ltd eases for fifth straight session
Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...
18 Nov 202413:35
Glenmark Pharma reports turnaround Q2 results
Revenue from operations increased 2.29% year on year (YoY) to Rs 3,133.79 crore in the qua...
15 Nov 202414:40
Glenmark Pharmaceuticals Ltd gains for third straight session
Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...
06 Nov 202413:05
Glenmark Pharmaceuticals declare Quarterly Result
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...
31 Oct 202412:07
Glenmark Pharmaceuticals Ltd spurts 2.21%
Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...
08 Oct 202413:05
Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection
The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...
23 Sep 202410:12
Unlimited trading at just
Rs. 199*